» Articles » PMID: 8870628

The UK Register of HIV Seroconverters: Methods and Analytical Issues. UK Register of HIV Seroconverters (UKRHS) Steering Committee

Overview
Date 1996 Oct 1
PMID 8870628
Citations 7
Affiliations
Soon will be listed here.
Abstract

A Register of HIV-infected persons who have had a negative antibody test within 3 years of their first antibody positive test (seroconverters) is being set up in the UK to monitor the distribution of times from HIV seroconversion to AIDS (the incubation period) and to death. It will also provide a national resource for use by those designing studies in this group of individuals. Clinicians caring for HIV-positive persons in Genito-Urinary Medicine, Infectious Disease and other departments throughout the UK were asked to participate by providing information on eligible subjects. Most laboratories undertaking HIV antibody testing were also contacted and asked to provide the name of the attending clinician for all seroconverters identified through the HIV laboratory reporting systems of the PHLS Communicable Disease Surveillance Centre (CDSC) and the Scottish Centre for Infection and Environmental Health (SCIEH) and for any other seroconverters known to them but not identified by CDSC or SCIEH. Data items sought for the Register include: sex, ethnic group, probable route of HIV transmission, annual CD4 counts, details of therapy and prophylaxis prescribed, AIDS-defining events and vital status. Follow up information is collected annually. Wherever possible, all seroconverters known to a clinic have been identified, whether currently alive or dead, either from clinic records or laboratory reporting or both. The objective is to establish and update a complete register of seroconverters on a long-term to basis to provide reliable estimates of the incubation period on which future projections of AIDS cases in the UK can be made.

Citing Articles

Associations between baseline characteristics, CD4 cell count response and virological failure on first-line efavirenz + tenofovir + emtricitabine for HIV.

Stirrup O, Sabin C, Phillips A, Williams I, Churchill D, Tostevin A J Virus Erad. 2019; 5(4):204-211.

PMID: 31754443 PMC: 6844404.


A qualitative study exploring the social and environmental context of recently acquired HIV infection among men who have sex with men in South-East England.

Gourlay A, Fox J, Gafos M, Fidler S, Nwokolo N, Clarke A BMJ Open. 2017; 7(8):e016494.

PMID: 28851787 PMC: 5629694. DOI: 10.1136/bmjopen-2017-016494.


Brief Report: Enhanced Normalization of CD4/CD8 Ratio With Earlier Antiretroviral Therapy at Primary HIV Infection.

Thornhill J, Inshaw J, Kaleebu P, Cooper D, Ramjee G, Schechter M J Acquir Immune Defic Syndr. 2016; 73(1):69-73.

PMID: 27070122 PMC: 4981213. DOI: 10.1097/QAI.0000000000001013.


The Impact of HCV Infection Duration on HIV Disease Progression and Response to cART amongst HIV Seroconverters in the UK.

Inshaw J, Leen C, Fisher M, Gilson R, Hawkins D, Collins S PLoS One. 2015; 10(7):e0132772.

PMID: 26225723 PMC: 4520682. DOI: 10.1371/journal.pone.0132772.


Role of HIV infection duration and CD4 cell level at initiation of combination anti-retroviral therapy on risk of failure.

Lodi S, Phillips A, Fidler S, Hawkins D, Gilson R, McLean K PLoS One. 2013; 8(9):e75608.

PMID: 24086588 PMC: 3782426. DOI: 10.1371/journal.pone.0075608.


References
1.
Hendriks J, Medley G, van Griensven G, Coutinho R, Heisterkamp S, van Druten H . The treatment-free incubation period of AIDS in a cohort of homosexual men. AIDS. 1993; 7(2):231-9. DOI: 10.1097/00002030-199302000-00012. View

2.
Gorham E, Garland F, Mayers D, Goforth R, Brodine S, Wiess P . CD4 lymphocyte counts within 24 months of human immunodeficiency virus seroconversion. Findings in the US Navy and Marine Corps. The Navy Retroviral Working Group. Arch Intern Med. 1993; 153(7):869-76. View

3.
Rosenberg P, Goedert J, Biggar R . Effect of age at seroconversion on the natural AIDS incubation distribution. Multicenter Hemophilia Cohort Study and the International Registry of Seroconverters. AIDS. 1994; 8(6):803-10. DOI: 10.1097/00002030-199406000-00013. View

4.
Phillips A, Sabin C, Elford J, Bofill M, Janossy G, Lee C . Use of CD4 lymphocyte count to predict long-term survival free of AIDS after HIV infection. BMJ. 1994; 309(6950):309-13. PMC: 2540903. DOI: 10.1136/bmj.309.6950.309. View

5.
Veugelers P, Page K, Tindall B, Schechter M, Moss A, Winkelstein Jr W . Determinants of HIV disease progression among homosexual men registered in the Tricontinental Seroconverter Study. Am J Epidemiol. 1994; 140(8):747-58. DOI: 10.1093/oxfordjournals.aje.a117322. View